About Index Trending news
Analyze
Pricing
SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics

SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.

Elsewhere

Alexa global traffic share

13 Mar 2014
$38,000,000
Venture capital (Series C)
16 Oct 2013
$20,000,000
Venture capital (Series B)
18 Oct 2011
$35,000,000
Venture capital (Series A)